Drugs Market Research Reports & Industry Analysis

... analgesia. Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to ... trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world. Parecoxib develops fast after entering China in 2008. ...

... Boehringer Ingelheim (Spain), Shenya Xin Ma Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceuticals Co., Ltd and Boehringer Ingelheim (Shanghai) occupy the majority of the Chinese market, among which Boehringer Ingelheim ...

... Merck Serono (rhFSH?), Livzon Pharmaceutical Group Co., Ltd (UFSH), IBSA (UFSH) and Organon (rhFSH?) dominate the Chinese market, among which Livzon Pharmaceutical Group Co., Ltd ...

... China in 1996. Pfizer, Inc., Zhejiang Jingxin Pharmaceutical Co., Ltd, Tianjin Huajin Pharmaceutical Factory, Guangdong P.D. Pharmaceutical Co., Ltd and Chengdu Leer Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Pfizer ...

... Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd ...

... JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory, Chuang Li Yao Ye, Kanion Pharmaceutical, Nanjing Luye Sike Pharma Co., Ltd and Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory ...

... GlaxoSmithKline (Tianjin) Co., Ltd, United Laboratories, Fujian Cosunter Pharmaceutical Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline (Tianjin) Co., Ltd ...

... GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited ...

... Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd ...

... of RNAII for injection made by different enterprises in China market outlook of RNAII for injection in China The author suggests the following groups of people purchase this report: manufacturers of immunomodulator investors ...

... Sino-American Shanghai Squibb occupy about 80% of the metformin market in China while the rest market share is taken up by such companies as Liling and Hebei Ideal & Hightech Pharmaceutical Co., Ltd. Apart from diabetes, metformin ...

... repaglinide of Novo Nordisk A/S came to be sold in China ... Hanson Pharmaceutical only occupies less than 11% of the market. The sales value of repaglinide ...

... Beijing Novartis Pharma Ltd. took up a market share of about 95% for sales value in 2014 while other companies like Deyuan Pharm, Luoxin Pharmacy Group Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd together occupied about 5% of the nateglinide market in China ...

... Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd took up a market share of about 86% for sales value and Sanofi occupied nearly 90% of the glimepiride market in China if Aventis (Italy ...

... Servier (France) and its subsidiary Servier (Tianjin) Pharmaceutical Co., Ltd took up a market share of about 96% for sales value in China while other companies like Tianjin Huajin Pharmaceutical Co., Ltd, Helioeast and Beijing Wansheng Pharmaceutical Co., Ltd ...

... Antibody Drug Conjugates (ADCs) in pipeline highlight the potential for new therapeutic innovations in the ADC industry. According to this edition of the report “Global Antibody Drug Conjugate Market Outlook 2020”, the ADC market is anticipated to reach around US$ 12.7 Billion by 2020. In our report, there is a detailed analysis of the market for ADCETRIS ...

... , the global erythropoietin market is expected to scale newer heights. The latest research by RNCOS titled “Global Erythropoietin Market Outlook 2020”, unfolds the market dynamics of the erythropoietin market. In this report, the global erythropoietin industry ... global market. Our industry analysts studied all the facets of the global erythropoietin market to portray a crystal-clear picture of the current as well as the expected future market outlook ...

... entitled “Global Microfluids Market Outlook 2020”, describes the overall microfluidics industry landscape with core emphasis on healthcare applications. According to analysis, the market for healthcare microfluidic devices was worth US$2.5 Billion in 2014 and is poised for a double digit growth during the forecasted period (2014-2020 ...

... titled “Global Vitamin and Supplements Market: Trends and Opportunities (2015-2019)” provides an insight into the vitamin and vitamin supplements market world-wide with focus on present market size and growth expected in the near future. The report analyzes the key vitamins – Vitamin B, Vitamin C, Vitamin ...

... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive ...

... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive ...

... identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The ... business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading ...

... , including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also ...

This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e. g. , DNA ...

This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other. The report also presents strategic ...

... probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Five-year test volume and reagent sales ... categories: - Infectious Diseases - Genetic Diseases - Cancer- Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies. Feature comparison of automated and ...

... Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country. Five-year test volume and sales forecasts by country. Contains 15 pages ...

... comprehensive analysis of the French molecular diagnostics market, including: Major issues pertaining to the French molecular diagnostics laboratory ... Diseases- Genetic Diseases- Cancer- Paternity Testing/HLA Typing- Forensic Testing Review of testing methodologies an instrumentation technologies. Feature ...

... comprehensive analysis of the German molecular diagnostics market, including: Major issues pertaining to the German molecular diagnostics laboratory ... Diseases- Genetic Diseases- Cancer- Paternity Testing/HLA Typing- Forensic Testing Review of testing methodologies an instrumentation technologies. Feature ...

... comprehensive analysis of the Italian molecular diagnostics market, including: Major issues pertaining to the Italian molecular diagnostics laboratory ... Diseases- Genetic Diseases- Cancer- Paternity Testing/HLA Typing- Forensic Testing Review of testing methodologies an instrumentation technologies. Feature ...

... comprehensive analysis of the Japanese molecular diagnostics market, including: Major issues pertaining to the Japanese molecular diagnostics laboratory ... Diseases - Genetic Diseases- Cancer - Paternity Testing/HLA Typing- Forensic Testing Review of testing methodologies an instrumentation technologies. Feature ...

The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 120 pages

... analysis of the Spanish molecular diagnostics market, including: Major issues pertaining to the Spanish molecular diagnostics laboratory ... Infectious DiseasesGenetic Diseases - Cancer - Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies. Feature ...

... - Forensic Testing- Cancer - Paternity Testing/HLA Typing- Genetic Diseases - Others- Five-year test volume and sales projections for over 30 NAT assays. - A comprehensive ... other suppliers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...

... probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales ... categories: - Infectious Diseases- Genetic Diseases- Cancer- Paternity Testing/HLA Typing- Forensic Testing Review of testing methodologies an instrumentation technologies. Feature comparison of automated and ...

This unique report from VPGMarketResearch provides Europe sales and market share estimates for major suppliers of molecular ...

This unique report from VPGMarketResearch provides UK sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological ...

This unique report from VPGMarketResearch provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological ...

... imipenem and cilastatin sodium in China competitive landscape of imipenem and cilastatin sodium in Chinese market price of imipenem and cilastatin sodium made by different enterprises in China market outlook of imipenem and cilastatin sodium in China ...

... China paclitaxel market include Nanjing Luye Pharma Group Sike Pharmaceutical Co., Ltd, The Department of Cancer, Bristol-Myers Squibb ...

... holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China. As an atypical antipsychotic, olanzapine ... life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding ...

... sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients. Currently, only sodium hyaluronate injection ...

... Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme ...

... cervus and cucumis polypeptide in the Chinese market all come from the following three companies: Gloria Pharmaceuticals Co., Ltd, Heilongjiang Dilong Pharmaceutical Co., Ltd and Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Gloria Pharmaceuticals Co., Ltd ...

... Novartis (Switzerland), Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd occupy the majority of the market share, among which Novartis ...

... Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia ...

... China. Currently, sodium ibandronate market in China is mainly occupied by the following companies: Science & Technology General Company Hebei Medical University, Roche Diagnostics GmbH GE), Hencer Pharmacy and Easton Pharmaceutical Co., Ltd, among which Science & Technology General Company Hebei Medical ...

... bone mass or osteoporosis while this figure is 30%-50% among women aged 60 and above. Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs ...

... Daiichi Sankyo Co., Ltd (Beijing), Yangtze River Pharmaceutical Group, China Resources Double Crane Pharmaceutical Co., Ltd, Santen Pharmaceutical Co., Ltd (Japan) and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory have occupied the majority of the market share, among which Daiichi Sankyo ...

... Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd ...